Case Studies / Quantum Blue

Why Wait for Results? The Benefits of Rapid and Point-of-Care Monitoring of Therapeutic Drugs

Biochemical testing to support clinical decision making is essential, but certain analytes are still not routinely tested in-house. For these, patient samples are sent away to a referral laboratory for

From BÜHLMANN Quantum Blue® to fCAL turbo®

Follow the Evolution of Calprotectin Testing at James Cook University Hospital This interview with Mr Andrew Teggert, Clinical Scientist, James Cook University Hospital, Middlesbrough, discusses recent changes made to the faecal calprotectin testing

Uganda_Case_Study
Out of Africa: Using Faecal Calprotectin Assays in the African Setting and Screening for Intestinal Schistosomiasis

Professor Russell Stothard and Dr Amaya Bustinduy Liverpool School of Tropical Medicine, London School of Hygiene and Tropical Medicine Our article highlights ongoing work in Uganda measuring morbidity associated with

The Pitfalls of Diagnosing IBS without Checking Calprotectin

In this case study, Arne Roseth reflects on a case last year where he met a patient who’d been wrongly diagnosed with IBS over 16 years ago. Last July I

Point of Care Testing for Calprotectin

Dr Sean Nugent, Consultant Gastroenterologist,of The Whitfield Clinic, Waterford, Ireland, talks to us about his introduction of the Quantum Blue Calprotectin Test into his clinic. Alpha Labs: Can you describe

Royal Berks takes a Quantum Leap

In autumn 2010, the Clinical Chemistry Dept at the Royal Berkshire Hospital decided to evaluate the Quantum Blue Calprotectin test. The reason was that their Calprotectin requests had grown sufficiently